期刊文献+

芹菜素对小鼠T淋巴细胞体外活化和增殖的抑制作用 被引量:1

The inhibitory effects of apigenin in the in vitro activation and proliferation of mouse lymphocytes
下载PDF
导出
摘要 研究芹菜素(apigenin,AP)对小鼠T细胞体外活化和增殖的影响,探讨其作用机制,以及将其开发为免疫抑制药物的可能。无菌分离小鼠淋巴结细胞,加入不同浓度(25μmol/L、50μmol/L、100μmol/L、150μmol/L和200μmol/L)的芹菜素预孵育4 h,用多克隆刺激剂刀豆蛋白A(concanavalin A,ConA)诱导T细胞活化和增殖,并用MTT法检测该药物浓度对T细胞的毒性作用。荧光标记抗体双染色结合流式细胞术,检测各浓度AP对ConA诱导的小鼠T细胞表达早期、中期和晚期活化抗原CD69、CD25和CD71的影响;以二乙酰羧基荧光素-琥珀酰亚胺酯(carboxyfluoresceindiacetate-succinim-idyl ester,CFDA-SE)染色结合流式细胞术,检测各浓度AP对ConA诱导的小鼠T细胞增殖的影响,并应用ModFit软件分析其增殖指数(proliferation index,PI)。结果显示,25-200μmol/L AP对ConA诱导的T细胞CD69、CD25的表达有显著抑制作用(P〈0.01),且呈剂量依赖关系;25μmol/L和50μmol/L的AP抑制CD71的表达,但高浓度(大于100μmol/L)才有显著抑制作用(P〈0.01)。各浓度AP对ConA诱导的T细胞增殖均有显著抑制作用(P〈0.01),且呈剂量依赖关系。表明在一定浓度范围内,AP可显著抑制ConA诱导的小鼠T细胞体外活化及增殖,有望通过进一步研究将其开发成免疫抑制药物。 To investigate the effects of apigenin on the activation and prolifrtation of mouse T lymphocytes in vitro, so as to elucidate its mechanism in order to develop a novel immunosuppressive drug, mouse lymphocytes were pre-treated with different concentration of apigenin(25, 50, 100 and 200μmol/L)for 4 hrs prior to stimulation with ConA. The cytotoxic effect of these concentrations of apigenin on T lymphocytes was assayed by MTT method, and those effects on the expressions of CD69, CD35 and CD71(the early, middle and late markers of the activated CD3^+T cells)on T lymphocytes in response to ConA stimulation were measured by flow cytometry combined with two colored flow cytometry. While, the effect of apigenin on the proliferation of T lymphocytes in response to ConA stimulation was determined by flow cytometry combined with carboxyl fluorescein-diacetate-succinimidyl ester(CFD-SE)technology, and the proliferation index(PI)was analyzed by Modfit software. The experiment results showed that apigenin at concentration of 25~200 μmol/I, could inhibit the expressions of CD69 and CD25 on T lyrnphocytes in response to ConA stimulation obviously(P〈0.01 ) in a dose-dependent manner. Apigenin at concentration of 25 and 50 μmol/L inhibited the expression of CD71, but marked effect of inhibition could be demonstrated under higher con-centration of apigenin(more than 100 μmol/L) in a dose-dependent manner(P〈0.01). It is evident from the above observation that apigenin can inhibit the activation and proliferation of mouse T lymphocytes in response to ConA stimulation in vitro, thus promising to be developed to immunosuppressive drug through further studies.
出处 《现代免疫学》 CAS CSCD 北大核心 2007年第6期481-487,共7页 Current Immunology
基金 973计划项目(2004CB720100 2006CB504200)
关键词 芹菜素 T淋巴细胞 活化 增殖 apigenin T cell activation proliferation
  • 相关文献

参考文献11

  • 1Chiang LC, Ng LT, Lin IC, et al. Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells [J]. Cancer Lett, 2006,237(2):207-214.
  • 2Khan TH, Sultana S. Apigenin induces apoptosis in Hep G2 cells: possible role of TNF-alpha and IFN-gamma[J]. Toxicology, 2006,217(2-3) :206-212.
  • 3Vargo MA, Voss OH, Poustka F, et al. Apigenin-inducedapoptosis is mediated by the activation of PKCdeha and caspases in leukemia cells[J]. Biochem Pharmacol, 2006,72 (6) :681-692.
  • 4Park J, Kim SH, Kim TS. Inhibition of interleukin-4 production in activated T cells via down-regulation of NF-AT DNA binding activity by apigenin, a flavonoid present in dietary plants[J]. Immunol Lett, 2006,103(2) : 108-114.
  • 5RealM, NcNerlan SE, Alexander HD. CD69, CD25, and HLA-DR activation antigen expression on CD3^+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging[J]. Exp Gerontol, 1999,34 ( 1 ) : 79- 93.
  • 6Lio D, Candore G, Cigna D, et al. In vitro T cell activation in elderly individuals: failure in CD69 and CD71 expression [J]. Mech Ageing Dev, 1996,89 (1):51-58.
  • 7Ryffel B, Willcocks JL, Brooks N, et al. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T- lymphocyte activation[J]. Immunopharmacology, 1995,30 (3):199-207.
  • 8常青,李守先,巩性军.免疫抑制剂降低同种带瓣主动脉移植后钙含量的观察[J].现代免疫学,2005,25(4):305-310. 被引量:1
  • 9李红梅,田甜,钱晓萍,孔宪涛,陈慰峰.流式细胞术测定淋巴细胞的分裂[J].上海免疫学杂志,2003,23(2):120-122. 被引量:7
  • 10Bektic J, Guggenberger R, Spengler B, et al. The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S[J]. Maturitas, 2006,55(1) :S37-46.

二级参考文献14

  • 1韩作宁,刘白,马树俊,陶家平,张志欣,志宏,龙振洲.PMA对人外周血T细胞和CD^(4+)细胞表型影响的研究[J].中华微生物学和免疫学杂志,1994,14(3):176-179. 被引量:4
  • 2周汝辟,薛昭华.见:毕爱华,主编,医学免疫学[M].北京:人民军医出版社,1996:275.
  • 3Mosmann T. Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays [J]. J Immunol Methods, 1983,65:55.
  • 4Claude P, Florence V. Sequential events in thymocyte differentiation and thymus regeneration revealed by a combination of bromedeoxyuridine DNA labeling and antimitic drug treatment[J]. J Immunol,1998,15:3315.
  • 5Abbas AK.Cellular and Molecular Immunology[M]. 3^rd ed. Philadelphia:W.B.Saunders Company 1997:139.
  • 6Ramsdell F,Jenkins M, Dinho O, et el. The majority of CD4^+ CD8^- thymoeytes are functionally immature[J] . J Immunol, 1991, 147:1779.
  • 7Nitta Y,Nelson K, Andrewa RG,et aI.CFSE dye dilution mixed lymphocyte reactions quantify donor-specific alloreactive precursors in nonhuman primate cardiac graft rejection [ J ] . Transplant Proc, 2001,33 :326.
  • 8Kanez BSW, Nunez R, Geimm F. Flow cytometry analysis of the effect of allopurinol and dinitroaniline compound(Chloralln) on the viability and proliferation of Leishmania infantum promastigotes[J]. BMC Pharmacol,2001,1 : 1.
  • 9Patel HR. Miller RA. Analysis of protein phosphorylation patterns reveals unanticipated complexity in T lymphocyte activation pathways[J].J Immunol, 1991,146: 3332.
  • 10顾晓.CD40共刺激通路与移植排斥反应[J].国外医学(泌尿系统分册),1999,19(6):263-265. 被引量:1

共引文献6

同被引文献12

  • 1肇静娴,曾耀英,刘毅,何贤辉.联合应用活体染料CFDA-SE和SNARF-1检测混合淋巴细胞反应[J].细胞与分子免疫学杂志,2006,22(3):382-384. 被引量:8
  • 2[1]Grohmann U,Fallarino F,Puccetti P.Tolerance,DCs and tryptophan:much ado about IDO[J].Trends Immunol,2003,24:242-248.
  • 3[2]Chen D,Sung R,Bromberg JS.Gene therapy in transplantation[J].Transpl Immunol,2002,9:301-314.
  • 4[4]Land W.Innate alloimmunity:history and current knowledge[J].Expclin Transplant,2007,5:575-584.
  • 5[6]Bubnoff D,Koch S,Bieber T.New jobs for an old enzyme:the revival of IDO[J].Trends Immunol,2003,24:296-297.
  • 6[7]Hainz U,Jürgens B,Heitger A.The role of indoleamine 2,3-dioxygenase in transplantation[J].Transplant Int,2007,20:118-127.
  • 7[8]Petroff MG.Immune interactions at the maternal-fetal interface[J].J Reprod Immunol,2005,68:1-13.
  • 8[9]Munn DH.Tumor immune evasion mediated by ID[M].Update On Cancer Therapeutis,2006:175-185.
  • 9[10]Alexander AM,Crawford M,Bertera S,et al.Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs gratt snrvlvat aster adoptive transter of diabetogenic splenocytes[J].Diabetes,2002,51:356-365.
  • 10[11]Li Y,Tredqet EE,Gaffari A,et al.Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute[J].J Invest Dermatol,2006,126:128-136.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部